The Los Angeles County Department of Public Health yesterday announced that it is investigating a fifth local dengue case, ...

Ken Paxton accuses the three big insulin manufacturers of conspiring with the three largest pharmacy companies to overcharge patients hundreds of dollars per dose while raking in sizable profits.

AUSTIN — Attorney General Ken Paxton sued major pharmaceutical makers and other companies Thursday, alleging they violated ...

In a phase 3 trial, tolebrutinib has a significant effect on slowing disability progression in some patients with multiple sclerosis..

By Sandra Agyeiwaa OTOO The Ghana Heart Initiative (GHI) that was established in January 2019 has successfully ended, paving the way for the AYA-Integrated Healthcare Initiative launch. This ...

The label expansion provides a new option for the hundreds of thousands of Americans with inadequately controlled COPD.

The Digital Markets, Competition and Consumers Act 2024 (UK DMCC) introduces significant reforms to the UK’s Competition and Markets Authority ...

The announcements by Cigna, CVS, Humana, Centene, and UnitedHealth were made ahead of the beginning of Medicare Advantage enrollment, which begins Oct. 15. Among other news, a top California health ...

Sanofi has asked bidders to revise their proposals for its consumer health unit, people with knowledge of the matter said, as ...

Plus, news about IN8bio, Sanofi, Vicore Pharma, Cartherics, Zephyrm Bioscience, Tharimmune and Intract Pharma: Biohaven’s $250M offering: The move comes after Biohaven announced Monday that it started ...

The FDA has approved Dupixent as an add-on maintenance treatment for adults with poorly controlled COPD and high counts of ...

Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, ...